Evidence mapPaperPMID 33923418Full record

ArticleJournal of clinical medicine2021

Non-Alcoholic Fatty Liver Disease Is Associated with Kidney Glomerular Hyperfiltration in Adults with Metabolic Syndrome.

Manuela Abbate, Catalina M Mascaró, Sofía Montemayor, Miguel Casares, Cristina Gómez, Lucia Ugarriza, Silvia Tejada, Itziar Abete, Maria Angeles Zulet, Antoni Sureda and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Recent Progress in Metabolic Syndrome Research and Therapeutics.International journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Manuela AbbateResearch Group in Community Nutrition and Oxidative Stress, University of the Balearic Islands-IUNICS, 07122 Palma de Mallorca, Spain.ORCID 0000-0001-9905-2414
Catalina M MascaróResearch Group in Community Nutrition and Oxidative Stress, University of the Balearic Islands-IUNICS, 07122 Palma de Mallorca, Spain.
Sofía MontemayorResearch Group in Community Nutrition and Oxidative Stress, University of the Balearic Islands-IUNICS, 07122 Palma de Mallorca, Spain.
Miguel CasaresRadiodiagnosis Service, Red Asistencial Juaneda, 07011 Palma de Mallorca, Spain.
Cristina GómezClinical Analysis Service, University Hospital Son Espases, 07120 Palma de Mallorca, Spain.
Lucia UgarrizaResearch Group in Community Nutrition and Oxidative Stress, University of the Balearic Islands-IUNICS, 07122 Palma de Mallorca, Spain.
Silvia TejadaResearch Group in Community Nutrition and Oxidative Stress, University of the Balearic Islands-IUNICS, 07122 Palma de Mallorca, Spain.
Itziar AbeteCIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Institute of Health Carlos III (ISCIII), 28029 Madrid, Spain.ORCID 0000-0002-6475-5387
Maria Angeles ZuletCIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Institute of Health Carlos III (ISCIII), 28029 Madrid, Spain.ORCID 0000-0002-3926-0892
Antoni SuredaResearch Group in Community Nutrition and Oxidative Stress, University of the Balearic Islands-IUNICS, 07122 Palma de Mallorca, Spain.ORCID 0000-0001-8656-6838
J Alfredo MartínezCIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Institute of Health Carlos III (ISCIII), 28029 Madrid, Spain.ORCID 0000-0001-5218-6941
Josep A TurResearch Group in Community Nutrition and Oxidative Stress, University of the Balearic Islands-IUNICS, 07122 Palma de Mallorca, Spain.ORCID 0000-0002-6940-0761
Instituto de Salud Carlos III · ESHealth Research Institute of the Balearic Islands · ESHospital Universitario Son Espases · ESMadrid Institute for Advanced Studies · ES

Funding

Balearic Islands Government 35/2011 and 23/2012COST COST Action CA16112European Regional Development Fund N/AFundacio La Marato TV3 201630.10Health Department of the Government of Navarra 61/2015IDISBA FOLIUM, PRIMUS, SYNERGIA, and LIBERIInstituto de salud carlos III Projects PI14/00636, PI17/01827, PI20/00456, and CIBEROBN CB12/03/30038, and Proyecto Intramural CIBER OBN18PI03Spanish Ministry of Education Catalina M. Mascaró received an FPU PhD Grant
6 · The paper itself

Abstract

backgroundNon-alcoholic fatty liver disease (NAFLD) is a risk factor for the development of chronic kidney disease (CKD), which is early marked by kidney glomerular hyperfiltration. However, the association of NAFLD with kidney glomerular hyperfiltration has not been tested so far in adults with metabolic syndrome (MetS).

aimsTo assess the relationship between NAFLD and kidney glomerular hyperfiltration in adults with MetS.

methodsThe study included 154 participants aged 40-60 years with MetS and NAFLD diagnosed by ultrasound. NAFLD was confirmed by MRI in 109 subjects. Participants underwent anthropometric measurements, and biochemistry testing. Estimated GFR (eGFR) was calculated using the CKD-Epidemiology Collaboration (CKD-EPI) formula; hyperfiltration was defined as eGFR ≥ 120 mL/min.

resultsParticipants with MRI-proven NAFLD showed a worse metabolic profile and higher levels of eGFR than those with no NAFLD. Presence of NAFLD and increased weight were independently associated with an increased probability of presenting hyperfiltration.

conclusionsThe present study shows an association between kidney glomerular hyperfiltration and NAFLD in adults with MetS. Establishing an association between NAFLD and kidney glomerular hyperfiltration would help to earlier identify those patients at increased risk of CKD, who would benefit from an early intervention.

Indexed as

eGFRglomerular hyperfiltrationkidneymetabolic syndromeNAFLDnon-alcoholic fatty liver disease

Identifiers

PMID33923418
PMCPMC8073467
OpenAlexW3153822916

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.